SN

Sunaina Nayak

Active Director Director DIN 10422540
DIN 10422540 First appointment Dec 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunaina Nayak

Data last updated:

Sunaina Nayak is a Director at Osmixa Biotech Private Limited (since 2026) and Director at Toynados Private Limited (since 2023).

DIN 10422540
Primary Designation Director
First Appointment 11 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Osmixa Biotech Private Limited U32503OD2026PTC052086
Director10 Jan 20262026Active
Toynados Private Limited U47640OD2023PTC044506
Director11 Dec 20232023Active

Board colleagues of Sunaina Nayak

Directorship timeline

Open interactive timeline →
Toynados Private Limited
Osmixa Biotech Private Limited
Premium access

Shareholding and investment profile for Sunaina Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunaina Nayak

Sunaina Nayak currently holds 2 directorships: Osmixa Biotech Private Limited (Director, since 10 Jan 2026); Toynados Private Limited (Director, since 11 Dec 2023).

Sunaina Nayak was first appointed on 11 Dec 2023 as Director at Toynados Private Limited. The most recent appointment on record is 10 Jan 2026 at Osmixa Biotech Private Limited.

The current boards of Sunaina Nayak's companies include Bhawani Shankar Meher (Osmixa Biotech Private Limited), Atanu Ranjan Nayak (Toynados Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available